Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
We aim to realise the long-term curative benefits of immunotherapy for more patients by devising new treatments, broadening the impact of existing treatments, and reducing side effects
Developments in Immuno-oncology

We aim to realise the long-term curative benefits of immunotherapy for more patients by devising new treatments, broadening the impact of existing treatments, and reducing side effects

Achieving NHS England’s Long Term Plan target to detect 75% cancers at an early stage by 2028 would mean an extra 55,000 patients per year will survive their cancer for at least 5 years
Early Cancer Detection

Achieving NHS England’s Long Term Plan target to detect 75% cancers at an early stage by 2028 would mean an extra 55,000 patients per year will survive their cancer for at least 5 years

Through the analysis of large, complex data sets, we can improve the patient experience by predicting and detecting cancer earlier, developing new treatments or optimising existing ones
Cancer Big Data

Through the analysis of large, complex data sets, we can improve the patient experience by predicting and detecting cancer earlier, developing new treatments or optimising existing ones

By developing new therapies and improving the utilisation of existing ones, Oxford researchers are improving the outcomes for cancer patients worldwide
Novel Therapeutics

By developing new therapies and improving the utilisation of existing ones, Oxford researchers are improving the outcomes for cancer patients worldwide

Oxford is home to over 60 research groups focusing on data science and its application to cancer research. Ranging from electronic patient record epidemiology and health-economic assessment, to computer vision, modelling and molecular informatics
Data Science

Oxford is home to over 60 research groups focusing on data science and its application to cancer research. Ranging from electronic patient record epidemiology and health-economic assessment, to computer vision, modelling and molecular informatics

Oxford has over 150 research groups across the city specialising in molecular, cellular, tissue and tissue-level processes that underpin health, disease and all life as we know it
Cell Biology & Tissue Physiology

Oxford has over 150 research groups across the city specialising in molecular, cellular, tissue and tissue-level processes that underpin health, disease and all life as we know it

Oxford is ranked top in Europe for immunology research and is home to 85 research groups seeking to build on this standard of excellence and apply it to all aspect of our understanding of cancer
Immunology

Oxford is ranked top in Europe for immunology research and is home to 85 research groups seeking to build on this standard of excellence and apply it to all aspect of our understanding of cancer

Based across the city of Oxford, researchers are developing cutting-edge technologies that integrate analytical and engineering science, to better treat and diagnose cancer patients
Physical Sciences & Drug Discovery

Based across the city of Oxford, researchers are developing cutting-edge technologies that integrate analytical and engineering science, to better treat and diagnose cancer patients

A global health project, bringing next generation technologies to Tanzania and Uganda, and improving the in-country testing process for EBV lymphomas.
AI-REAL

A global health project, bringing next generation technologies to Tanzania and Uganda, and improving the in-country testing process for EBV lymphomas.

A follow-on clinical trial investigating antimalarial drug Atovaquone as a method to improve the impact of chemoradiotherapy
ARCADIAN

A follow-on clinical trial investigating antimalarial drug Atovaquone as a method to improve the impact of chemoradiotherapy

A research study into methods of early detection of hepatocellular liver cancer, using novel blood tests, imaging technologies and next generation sequencing to identify new biomarkers and underlying mechanisms that can lead to cancer progression
DeLIVER

A research study into methods of early detection of hepatocellular liver cancer, using novel blood tests, imaging technologies and next generation sequencing to identify new biomarkers and underlying mechanisms that can lead to cancer progression

An observational cohort study to identify early detection markers for malignant blood cancers such as CLL and MGUS
OxPLoreD

An observational cohort study to identify early detection markers for malignant blood cancers such as CLL and MGUS

Developing novel drug delivery systems using ultrasound, capable of enhancing drug penetration into and around a tumour, whilst minimising patient toxicity.
PanDox

Developing novel drug delivery systems using ultrasound, capable of enhancing drug penetration into and around a tumour, whilst minimising patient toxicity.

Improving early detection of cancer through novel liquid-biopsy based diagnostic tests, that are specific and sensitive enough to test for a variety of cancers.
TAPS Technology

Improving early detection of cancer through novel liquid-biopsy based diagnostic tests, that are specific and sensitive enough to test for a variety of cancers.

A prospective study using the largest data-base of its kind, collecting information on new potential risk factors for women and ultimately informing public health policies
The Million Women Study

A prospective study using the largest data-base of its kind, collecting information on new potential risk factors for women and ultimately informing public health policies

A multi-disciplinary clinical trial and research project investigating new immunotherapy drug opportunities in oesophageal cancer.
LUD2015-005

A multi-disciplinary clinical trial and research project investigating new immunotherapy drug opportunities in oesophageal cancer.

Using data collected by the NHS Lung Health Check programme to develop and validate Artificial Intelligence to more accurately and quickly diagnose lung disease
DART

Using data collected by the NHS Lung Health Check programme to develop and validate Artificial Intelligence to more accurately and quickly diagnose lung disease

Oxford's Pancreatic Network
PancrImmune

Oxford's Pancreatic Network

The international partnership for developing a gastrointestinal cancer plan
Sichuan University (West China Hospital)-Oxford University Gastrointestinal Cancer Centre

The international partnership for developing a gastrointestinal cancer plan

Stratification in Colorectal Cancer
S:CORT

Stratification in Colorectal Cancer

Oxford's Colorectal Cancer Stratified Medicine Network
ACRCelerate

Oxford's Colorectal Cancer Stratified Medicine Network

Advanced Radiotherapy Technologies Network
ART-NET

Advanced Radiotherapy Technologies Network

Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer
EHNBPCCG

Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer

Improving Immunotherapy treatment for cancer patients
Southampton Immune Accelerator

Improving Immunotherapy treatment for cancer patients

Driving innovation in the use of artificial intelligence (AI) for improved diagnosis and treatment in cancer
National Consortium for Intelligent Medical Imaging (NCIMI)

Driving innovation in the use of artificial intelligence (AI) for improved diagnosis and treatment in cancer

Pathology image data Lake for Education, Analytics and Discovery
PathLAKE

Pathology image data Lake for Education, Analytics and Discovery

A network of medical imaging experts working towards discovery, validation and adoption of cancer imaging biomarkers
National Cancer Imaging Translational Accelerator (NCITA)

A network of medical imaging experts working towards discovery, validation and adoption of cancer imaging biomarkers